APA aipamena

Giakoustidis, A., Neofytou, K., Khan, A., & Mudan, S. (2014). Addition of bevacizumab to preoperative chemotherapy for colorectal liver metastases does not increase perioperative morbidity and mortality. Hepat Oncol.

Chicago Style aipamena

Giakoustidis, Alexandros, Kyriakos Neofytou, Aamir Khan, and Satvinder Mudan. "Addition of Bevacizumab to Preoperative Chemotherapy for Colorectal Liver Metastases Does Not Increase Perioperative Morbidity and Mortality." Hepat Oncol 2014.

MLA aipamena

Giakoustidis, Alexandros, Kyriakos Neofytou, Aamir Khan, and Satvinder Mudan. "Addition of Bevacizumab to Preoperative Chemotherapy for Colorectal Liver Metastases Does Not Increase Perioperative Morbidity and Mortality." Hepat Oncol 2014.